3-amino-6-(1H-indazol-5-yl)-N-(2-methoxyphenyl)pyrazine-2-carboxamide;2-[3-amino-6-(4-methylsulfonylphenyl)pyrazin-2-yl]-3H-benzimidazole-5-carbonitrile;2-[3-amino-6-(4-methylsulfonylphenyl)pyrazin-2-yl]-1H-benzimidazol-4-ol;3-(1H-benzimidazol-2-yl)-5-phenylpyrazin-2-amine;3-(1H-imidazo[4,5-b]pyridin-2-yl)-5-(4-methylsulfonylphenyl)pyrazin-2-amine;molecular hydrogen

C90H86N28O9S3 — CID 157265685

IUPAC3-amino-6-(1H-indazol-5-yl)-N-(2-methoxyphenyl)pyrazine-2-carboxamide;2-[3-amino-6-(4-methylsulfonylphenyl)pyrazin-2-yl]-3H-benzimidazole-5-carbonitrile;2-[3-amino-6-(4-methylsulfonylphenyl)pyrazin-2-yl]-1H-benzimidazol-4-ol;3-(1H-benzimidazol-2-yl)-5-phenylpyrazin-2-amine;3-(1H-imidazo[4,5-b]pyridin-2-yl)-5-(4-methylsulfonylphenyl)pyrazin-2-amine;molecular hydrogen
SMILESCOc1ccccc1NC(=O)c1nc(-c2ccc3[nH]ncc3c2)cnc1N.CS(=O)(=O)c1ccc(-c2cnc(N)c(-c3nc4c(O)cccc4[nH]3)n2)cc1.CS(=O)(=O)c1ccc(-c2cnc(N)c(-c3nc4ccc(C#N)cc4[nH]3)n2)cc1.CS(=O)(=O)c1ccc(-c2cnc(N)c(-c3nc4ncccc4[nH]3)n2)cc1.Nc1ncc(-c2ccccc2)nc1-c1nc2ccccc2[nH]1.[H][H].[H][H].[H][H].[H][H].[H][H].[H][H].[H][H]
InChIInChI=1S/C19H14N6O2S.C19H16N6O2.C18H15N5O3S.C17H14N6O2S.C17H13N5.7H2/c1-28(26,27)13-5-3-12(4-6-13)16-10-22-18(21)17(23-16)19-24-14-7-2-11(9-20)8-15(14)25-19;1-27-16-5-3-2-4-14(16)24-19(26)17-18(20)21-10-15(23-17)11-6-7-13-12(8-11)9-22-25-13;1-27(25,26)11-7-5-10(6-8-11)13-9-20-17(19)16(21-13)18-22-12-3-2-4-14(24)15(12)23-18;1-26(24,25)11-6-4-10(5-7-11)13-9-20-15(18)14(21-13)17-22-12-3-2-8-19-16(12)23-17;18-16-15(17-21-12-8-4-5-9-13(12)22-17)20-14(10-19-16)11-6-2-1-3-7-11;;;;;;;/h2-8,10H,1H3,(H2,21,22)(H,24,25);2-10H,1H3,(H2,20,21)(H,22,25)(H,24,26);2-9,24H,1H3,(H2,19,20)(H,22,23);2-9H,1H3,(H2,18,20)(H,19,22,23);1-10H,(H2,18,19)(H,21,22);7*1H
InChIKeyAXYVEUYMCCBRTD-UHFFFAOYSA-N
MW1800.07 g/mol
LogP14.84
Rot. Bonds15

About 3-amino-6-(1H-indazol-5-yl)-N-(2-methoxyphenyl)pyrazine-2-carboxamide;2-[3-amino-6-(4-methylsulfonylphenyl)pyrazin-2-yl]-3H-benzimidazole-5-carbonitrile;2-[3-amino-6-(4-methylsulfonylphenyl)pyrazin-2-yl]-1H-benzimidazol-4-ol;3-(1H-benzimidazol-2-yl)-5-phenylpyrazin-2-amine;3-(1H-imidazo[4,5-b]pyridin-2-yl)-5-(4-methylsulfonylphenyl)pyrazin-2-amine;molecular hydrogen

3-amino-6-(1H-indazol-5-yl)-N-(2-methoxyphenyl)pyrazine-2-carboxamide;2-[3-amino-6-(4-methylsulfonylphenyl)pyrazin-2-yl]-3H-benzimidazole-5-carbonitrile;2-[3-amino-6-(4-methylsulfonylphenyl)pyrazin-2-yl]-1H-benzimidazol-4-ol;3-(1H-benzimidazol-2-yl)-5-phenylpyrazin-2-amine;3-(1H-imidazo[4,5-b]pyridin-2-yl)-5-(4-methylsulfonylphenyl)pyrazin-2-amine;molecular hydrogen (PubChem CID 157265685) has the molecular formula C90H86N28O9S3 and a molecular weight of 1800.07 g/mol. Its IUPAC name is 3-amino-6-(1H-indazol-5-yl)-N-(2-methoxyphenyl)pyrazine-2-carboxamide;2-[3-amino-6-(4-methylsulfonylphenyl)pyrazin-2-yl]-3H-benzimidazole-5-carbonitrile;2-[3-amino-6-(4-methylsulfonylphenyl)pyrazin-2-yl]-1H-benzimidazol-4-ol;3-(1H-benzimidazol-2-yl)-5-phenylpyrazin-2-amine;3-(1H-imidazo[4,5-b]pyridin-2-yl)-5-(4-methylsulfonylphenyl)pyrazin-2-amine;molecular hydrogen.

Molecular Properties

Compound Name3-amino-6-(1H-indazol-5-yl)-N-(2-methoxyphenyl)pyrazine-2-carboxamide;2-[3-amino-6-(4-methylsulfonylphenyl)pyrazin-2-yl]-3H-benzimidazole-5-carbonitrile;2-[3-amino-6-(4-methylsulfonylphenyl)pyrazin-2-yl]-1H-benzimidazol-4-ol;3-(1H-benzimidazol-2-yl)-5-phenylpyrazin-2-amine;3-(1H-imidazo[4,5-b]pyridin-2-yl)-5-(4-methylsulfonylphenyl)pyrazin-2-amine;molecular hydrogen
PubChem CID157265685
Molecular FormulaC90H86N28O9S3
Molecular Weight1800.07 g/mol
Exact Mass1798.63
IUPAC Name3-amino-6-(1H-indazol-5-yl)-N-(2-methoxyphenyl)pyrazine-2-carboxamide;2-[3-amino-6-(4-methylsulfonylphenyl)pyrazin-2-yl]-3H-benzimidazole-5-carbonitrile;2-[3-amino-6-(4-methylsulfonylphenyl)pyrazin-2-yl]-1H-benzimidazol-4-ol;3-(1H-benzimidazol-2-yl)-5-phenylpyrazin-2-amine;3-(1H-imidazo[4,5-b]pyridin-2-yl)-5-(4-methylsulfonylphenyl)pyrazin-2-amine;molecular hydrogen
SMILESCOc1ccccc1NC(=O)c1nc(-c2ccc3[nH]ncc3c2)cnc1N.CS(=O)(=O)c1ccc(-c2cnc(N)c(-c3nc4c(O)cccc4[nH]3)n2)cc1.CS(=O)(=O)c1ccc(-c2cnc(N)c(-c3nc4ccc(C#N)cc4[nH]3)n2)cc1.CS(=O)(=O)c1ccc(-c2cnc(N)c(-c3nc4ncccc4[nH]3)n2)cc1.Nc1ncc(-c2ccccc2)nc1-c1nc2ccccc2[nH]1.[H][H].[H][H].[H][H].[H][H].[H][H].[H][H].[H][H]
InChIInChI=1S/C19H14N6O2S.C19H16N6O2.C18H15N5O3S.C17H14N6O2S.C17H13N5.7H2/c1-28(26,27)13-5-3-12(4-6-13)16-10-22-18(21)17(23-16)19-24-14-7-2-11(9-20)8-15(14)25-19;1-27-16-5-3-2-4-14(16)24-19(26)17-18(20)21-10-15(23-17)11-6-7-13-12(8-11)9-22-25-13;1-27(25,26)11-7-5-10(6-8-11)13-9-20-17(19)16(21-13)18-22-12-3-2-4-14(24)15(12)23-18;1-26(24,25)11-6-4-10(5-7-11)13-9-20-15(18)14(21-13)17-22-12-3-2-8-19-16(12)23-17;18-16-15(17-21-12-8-4-5-9-13(12)22-17)20-14(10-19-16)11-6-2-1-3-7-11;;;;;;;/h2-8,10H,1H3,(H2,21,22)(H,24,25);2-10H,1H3,(H2,20,21)(H,22,25)(H,24,26);2-9,24H,1H3,(H2,19,20)(H,22,23);2-9H,1H3,(H2,18,20)(H,19,22,23);1-10H,(H2,18,19)(H,21,22);7*1H
InChIKeyAXYVEUYMCCBRTD-UHFFFAOYSA-N
XLogP14.84
TPSA600.06 Ų
H-Bond Donors12
H-Bond Acceptors31
Rotatable Bonds15
Heavy Atoms130
Complexity—

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5001800.07
LogP ≤ 514.84
H-Bond Donors ≤ 512
H-Bond Acceptors ≤ 1031

Analyze 3-amino-6-(1H-indazol-5-yl)-N-(2-methoxyphenyl)pyrazine-2-carboxamide;2-[3-amino-6-(4-methylsulfonylphenyl)pyrazin-2-yl]-3H-benzimidazole-5-carbonitrile;2-[3-amino-6-(4-methylsulfonylphenyl)pyrazin-2-yl]-1H-benzimidazol-4-ol;3-(1H-benzimidazol-2-yl)-5-phenylpyrazin-2-amine;3-(1H-imidazo[4,5-b]pyridin-2-yl)-5-(4-methylsulfonylphenyl)pyrazin-2-amine;molecular hydrogen with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

2-[3-amino-6-(4-methylsulfonylphenyl)pyrazin-2-yl]-3H-benzimidazole-5-carbonitrile;2-[3-amino-6-(4-methylsulfonylphenyl)pyrazin-2-yl]-1H-benzimidazol-4-ol;2-(3-amino-6-phenylpyrazin-2-yl)-1H-benzimidazol-4-ol;3-(1H-benzimidazol-2-yl)-5-phenylpyrazin-2-amine;3-(1H-imidazo[4,5-b]pyridin-2-yl)-5-(4-methylsulfonylphenyl)pyrazin-2-amine
CID 161163420
3-amino-N-(2-methoxy-5-methylphenyl)-6-pyridin-3-ylpyrazine-2-carboxamide;2-[3-amino-6-(4-methylsulfonylphenyl)pyrazin-2-yl]-3H-benzimidazole-5-carbonitrile;2-[3-amino-6-(4-methylsulfonylphenyl)pyrazin-2-yl]-1H-benzimidazol-4-ol;3-(1H-benzimidazol-2-yl)-5-phenylpyrazin-2-amine;3-(1H-imidazo[4,5-b]pyridin-2-yl)-5-(4-methylsulfonylphenyl)pyrazin-2-amine;molecular hydrogen
CID 162143138

Frequently Asked Questions

What is the IUPAC name of 3-amino-6-(1H-indazol-5-yl)-N-(2-methoxyphenyl)pyrazine-2-carboxamide;2-[3-amino-6-(4-methylsulfonylphenyl)pyrazin-2-yl]-3H-benzimidazole-5-carbonitrile;2-[3-amino-6-(4-methylsulfonylphenyl)pyrazin-2-yl]-1H-benzimidazol-4-ol;3-(1H-benzimidazol-2-yl)-5-phenylpyrazin-2-amine;3-(1H-imidazo[4,5-b]pyridin-2-yl)-5-(4-methylsulfonylphenyl)pyrazin-2-amine;molecular hydrogen?
The IUPAC name of 3-amino-6-(1H-indazol-5-yl)-N-(2-methoxyphenyl)pyrazine-2-carboxamide;2-[3-amino-6-(4-methylsulfonylphenyl)pyrazin-2-yl]-3H-benzimidazole-5-carbonitrile;2-[3-amino-6-(4-methylsulfonylphenyl)pyrazin-2-yl]-1H-benzimidazol-4-ol;3-(1H-benzimidazol-2-yl)-5-phenylpyrazin-2-amine;3-(1H-imidazo[4,5-b]pyridin-2-yl)-5-(4-methylsulfonylphenyl)pyrazin-2-amine;molecular hydrogen (CID 157265685) is 3-amino-6-(1H-indazol-5-yl)-N-(2-methoxyphenyl)pyrazine-2-carboxamide;2-[3-amino-6-(4-methylsulfonylphenyl)pyrazin-2-yl]-3H-benzimidazole-5-carbonitrile;2-[3-amino-6-(4-methylsulfonylphenyl)pyrazin-2-yl]-1H-benzimidazol-4-ol;3-(1H-benzimidazol-2-yl)-5-phenylpyrazin-2-amine;3-(1H-imidazo[4,5-b]pyridin-2-yl)-5-(4-methylsulfonylphenyl)pyrazin-2-amine;molecular hydrogen.
What is the SMILES notation for 3-amino-6-(1H-indazol-5-yl)-N-(2-methoxyphenyl)pyrazine-2-carboxamide;2-[3-amino-6-(4-methylsulfonylphenyl)pyrazin-2-yl]-3H-benzimidazole-5-carbonitrile;2-[3-amino-6-(4-methylsulfonylphenyl)pyrazin-2-yl]-1H-benzimidazol-4-ol;3-(1H-benzimidazol-2-yl)-5-phenylpyrazin-2-amine;3-(1H-imidazo[4,5-b]pyridin-2-yl)-5-(4-methylsulfonylphenyl)pyrazin-2-amine;molecular hydrogen?
The canonical SMILES for 3-amino-6-(1H-indazol-5-yl)-N-(2-methoxyphenyl)pyrazine-2-carboxamide;2-[3-amino-6-(4-methylsulfonylphenyl)pyrazin-2-yl]-3H-benzimidazole-5-carbonitrile;2-[3-amino-6-(4-methylsulfonylphenyl)pyrazin-2-yl]-1H-benzimidazol-4-ol;3-(1H-benzimidazol-2-yl)-5-phenylpyrazin-2-amine;3-(1H-imidazo[4,5-b]pyridin-2-yl)-5-(4-methylsulfonylphenyl)pyrazin-2-amine;molecular hydrogen is COc1ccccc1NC(=O)c1nc(-c2ccc3[nH]ncc3c2)cnc1N.CS(=O)(=O)c1ccc(-c2cnc(N)c(-c3nc4c(O)cccc4[nH]3)n2)cc1.CS(=O)(=O)c1ccc(-c2cnc(N)c(-c3nc4ccc(C#N)cc4[nH]3)n2)cc1.CS(=O)(=O)c1ccc(-c2cnc(N)c(-c3nc4ncccc4[nH]3)n2)cc1.Nc1ncc(-c2ccccc2)nc1-c1nc2ccccc2[nH]1.[H][H].[H][H].[H][H].[H][H].[H][H].[H][H].[H][H].
What is the InChIKey of 3-amino-6-(1H-indazol-5-yl)-N-(2-methoxyphenyl)pyrazine-2-carboxamide;2-[3-amino-6-(4-methylsulfonylphenyl)pyrazin-2-yl]-3H-benzimidazole-5-carbonitrile;2-[3-amino-6-(4-methylsulfonylphenyl)pyrazin-2-yl]-1H-benzimidazol-4-ol;3-(1H-benzimidazol-2-yl)-5-phenylpyrazin-2-amine;3-(1H-imidazo[4,5-b]pyridin-2-yl)-5-(4-methylsulfonylphenyl)pyrazin-2-amine;molecular hydrogen?
The InChIKey is AXYVEUYMCCBRTD-UHFFFAOYSA-N. The full InChI is InChI=1S/C19H14N6O2S.C19H16N6O2.C18H15N5O3S.C17H14N6O2S.C17H13N5.7H2/c1-28(26,27)13-5-3-12(4-6-13)16-10-22-18(21)17(23-16)19-24-14-7-2-11(9-20)8-15(14)25-19;1-27-16-5-3-2-4-14(16)24-19(26)17-18(20)21-10-15(23-17)11-6-7-13-12(8-11)9-22-25-13;1-27(25,26)11-7-5-10(6-8-11)13-9-20-17(19)16(21-13)18-22-12-3-2-4-14(24)15(12)23-18;1-26(24,25)11-6-4-10(5-7-11)13-9-20-15(18)14(21-13)17-22-12-3-2-8-19-16(12)23-17;18-16-15(17-21-12-8-4-5-9-13(12)22-17)20-14(10-19-16)11-6-2-1-3-7-11;;;;;;;/h2-8,10H,1H3,(H2,21,22)(H,24,25);2-10H,1H3,(H2,20,21)(H,22,25)(H,24,26);2-9,24H,1H3,(H2,19,20)(H,22,23);2-9H,1H3,(H2,18,20)(H,19,22,23);1-10H,(H2,18,19)(H,21,22);7*1H.
What are the key properties of 3-amino-6-(1H-indazol-5-yl)-N-(2-methoxyphenyl)pyrazine-2-carboxamide;2-[3-amino-6-(4-methylsulfonylphenyl)pyrazin-2-yl]-3H-benzimidazole-5-carbonitrile;2-[3-amino-6-(4-methylsulfonylphenyl)pyrazin-2-yl]-1H-benzimidazol-4-ol;3-(1H-benzimidazol-2-yl)-5-phenylpyrazin-2-amine;3-(1H-imidazo[4,5-b]pyridin-2-yl)-5-(4-methylsulfonylphenyl)pyrazin-2-amine;molecular hydrogen?
3-amino-6-(1H-indazol-5-yl)-N-(2-methoxyphenyl)pyrazine-2-carboxamide;2-[3-amino-6-(4-methylsulfonylphenyl)pyrazin-2-yl]-3H-benzimidazole-5-carbonitrile;2-[3-amino-6-(4-methylsulfonylphenyl)pyrazin-2-yl]-1H-benzimidazol-4-ol;3-(1H-benzimidazol-2-yl)-5-phenylpyrazin-2-amine;3-(1H-imidazo[4,5-b]pyridin-2-yl)-5-(4-methylsulfonylphenyl)pyrazin-2-amine;molecular hydrogen has a molecular weight of 1800.07 g/mol, XLogP of 14.84, 15 rotatable bonds, 12 hydrogen bond donors, and 31 hydrogen bond acceptors.
Where does this data come from?
All data for 3-amino-6-(1H-indazol-5-yl)-N-(2-methoxyphenyl)pyrazine-2-carboxamide;2-[3-amino-6-(4-methylsulfonylphenyl)pyrazin-2-yl]-3H-benzimidazole-5-carbonitrile;2-[3-amino-6-(4-methylsulfonylphenyl)pyrazin-2-yl]-1H-benzimidazol-4-ol;3-(1H-benzimidazol-2-yl)-5-phenylpyrazin-2-amine;3-(1H-imidazo[4,5-b]pyridin-2-yl)-5-(4-methylsulfonylphenyl)pyrazin-2-amine;molecular hydrogen is sourced from PubChem (CID 157265685), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).